Jacqueline S. Daly

Jacqueline S. Daly

Auto-generated profile, based on publicly available information

Jacqueline S. Daly

Division of Biology, Department of Anatomy and Regenerative Medicine, RCSI University of Medicine and Health Sciences, Dublin 2 D02 YN77, Ireland

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PGPiergiorgio Gentile
Piergiorgio Gentile
VNVijay Kumar Nandagiri
Vijay Kumar Nandagiri
RPRitesh Pabari
Ritesh Pabari
JDJacqueline Daly
Jacqueline Daly
CTChiara Tonda-Turo
Chiara Tonda-Turo
ZRZebunnissa Ramtoola
Zebunnissa Ramtoola
Biodegradable poly(lactide-co-glycolide) (PLGA) nanoparticles, containing human parathyroid hormone (PTH (1–34)), prepared by a modified double emulsion-solvent diffusion-evaporation method, were incorporated in porous freeze-dried chitosan-gelatin (CH-G) scaffolds. The PTH-loaded nanoparticles (NPTH) were characterised in terms of morphology, size, protein loading, release kinetics and in vitro assessment of biological activity of released PTH and cytocompatibility studies against clonal human osteoblast (hFOB) cells. Structural integrity of incorporated and released PTH from nanoparticles was found to be intact by using Tris-tricine SDS-PAGE. In vitro PTH release kinetics from PLGA nanoparticles were characterised by a burst release followed by a slow release phase for 3–4 weeks. The released PTH was biologically active as evidenced by the stimulated release of cyclic AMP from hFOB cells as well as increased mineralisation studies. in vitro and cell studies demonstrated that the PTH bioactivity was maintained during the fabrication of PLGA nanoparticles and upon release. Finally, a content of 33.3% w/w NPTHs was incorporated in CH-G scaffolds, showing an intermittent release during the first 10 days and, followed by a controlled release over 28 days of observation time. The increased expression of Alkaline Phosphatase levels on hFOB cells further confirmed the activity of intermittently released PTH from scaffolds.

1 November 2016 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
SVSundaram G. Veerappan
Sundaram G. Veerappan
MHMartin Healy
Martin Healy
BWBernard Walsh
Bernard Walsh
COColm A. O’morain
Colm A. O’morain
JDJacqueline S. Daly
Jacqueline S. Daly
BRBarbara M. Ryan
Barbara M. Ryan
IFX treatment induced beneficial effects on bone metabolism. Osteoblast culture results suggest that IBD patients may have increased osteoblast viability, but reduced differentiation, which has implications for bone strength.

19 November 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
LMLauren Mohan
Lauren Mohan
LMLauren McDonald
Lauren McDonald
JDJacqueline S. Daly
Jacqueline S. Daly
ZRZebunnissa Ramtoola
Zebunnissa Ramtoola
Oral nanomedicines are being investigated as an innovative strategy for targeted drug delivery to treat inflammatory bowel diseases. Preclinical studies have shown that nanoparticles (NPs) can preferentially penetrate inflamed intestinal tissues, allowing for targeted drug delivery. NP size is a critical factor affecting their interaction with the inflamed intestinal barrier and this remains poorly defined. In this study we aimed to assess the impact of NP particle size (PS) and polydispersity (PDI) on cell interaction and uptake in an inflamed epithelial cell model. Using 10, 55 and 100 mg/mL poly(lactic-co-glycolic acid)-polyethylene glycol (PLGA-PEG), NPs of 131, 312 and 630 nm PS, respectively, were formulated by solvent dispersion. NP recovery was optimised by differential centrifugation to yield NPs of decreased and unimodal size distribution. NP-cell interaction was assessed in healthy and inflamed caco-2 cell monolayers. Results show that NP interaction with caco-2 cells increased with increasing PS and PDI and was significantly enhanced in inflamed cells. Trypan blue quenching revealed that a significant proportion of multimodal NPs were primarily membrane bound, while monomodal NPs were internalized within cells. These results are interesting as the PS and PDI of NPs can be optimised to allow targeting of therapeutic agents to the epithelial membrane and/or intracellular targets in the inflamed intestinal epithelium.

3 March 2015 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
SVSundaram G. Veerappan
Sundaram G. Veerappan
MHMartin Healy
Martin Healy
BWBernard J. Walsh
Bernard J. Walsh
COColm A. O’morain
Colm A. O’morain
JDJacqueline S. Daly
Jacqueline S. Daly
BRBarbara M. Ryan
Barbara M. Ryan

30 April 2000 in Gastroenterology
Verified
Journal Article
Closed access
BRBarbara M. Ryan
Barbara M. Ryan
RMRoss Mc Manus
Ross Mc Manus
JDJacqueline S. Daly
Jacqueline S. Daly
FLFrancois LeFort
Francois LeFort
NKNapoleon Keeling
Napoleon Keeling
DKDermot Kelleher
Dermot Kelleher

30 April 2000 in Gastroenterology
Verified
Journal Article
Closed access
JDJacqueline S. Daly
Jacqueline S. Daly
RMRoss Mc Manus
Ross Mc Manus
RWRosemary Whelan
Rosemary Whelan
BRBarbara Ryan
Barbara Ryan
YAYeng Shiong Ang
Yeng Shiong Ang
DKDermot Kelleher
Dermot Kelleher